Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Renal Cell Cancer AJCC v7”

171 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 171 results

Testing effectiveness (Phase 2)Ended earlyNCT00496756
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Nebraska 14
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT00087022
What this trial is testing

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Heidelberg Pharma AG 864
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)WithdrawnNCT00311545
What this trial is testing

S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network
Very early researchStudy completedNCT00405366
What this trial is testing

Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00467077
What this trial is testing

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
California Cancer Consortium 21
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Study completedNCT00459979
What this trial is testing

Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 30
Not applicableStudy completedNCT00849186
What this trial is testing

Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Roswell Park Cancer Institute 20
Large-scale testing (Phase 3)Active Not RecruitingNCT01575548
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 129
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00032188
What this trial is testing

Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 65
Large-scale testing (Phase 3)Active Not RecruitingNCT03055013
What this trial is testing

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Who this might be right for
Metastatic Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v7+2 more
National Cancer Institute (NCI) 819
Testing effectiveness (Phase 2)Active Not RecruitingNCT03284385
What this trial is testing

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid Neoplasm+4 more
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Study completedNCT01120249
What this trial is testing

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 1,545
Testing effectiveness (Phase 2)Study completedNCT00335556
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Who this might be right for
Childhood Renal Cell CarcinomaClear Cell Renal Cell CarcinomaClear Cell Sarcoma of the Kidney+10 more
Children's Oncology Group 291
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Next Page